Atxn3 | ataxin 3
Physiological systems
18 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system
16 No significant impact
6 Not tested
Data collections
Gene metrics:3Significant phenotypes
5Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
decreased circulating fructosamine level | 1 supporting dataset | Atxn3tm1a(KOMP)Wtsi | homozygote | Early adult | 6.98x10-5 | ||
increased circulating aspartate transaminase level | 1 supporting dataset | Atxn3tm1a(KOMP)Wtsi | homozygote | Early adult | 2.62x10-5 | ||
increased anti-nuclear antigen antibody level | 4 supporting datasets | Atxn3tm1a(KOMP)Wtsi | homozygote | Early adult | N/A * |
| | | | | | | | | |
External links
No external links available for Atxn3.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Atxn3tm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector es cell mouse |
Atxn3tm1e(KOMP)Wtsi | Targeted, non-conditional allele | | es cell |